Transcripts Viracta Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-08 pm EDT			5-day change	1st Jan Change
0.821 ^USD	+0.12%		+0.17%	+44.04%

Apr. 15	Viracta Therapeutics, Inc. Reports Positive Topline Results from Stage 1 of the Pivotal Phase 2 NAVAL-1 Trial	CI
Apr. 01	Viracta Therapeutics to Present Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial at the 2024 Annual Congress of The Hematology Society of Taiwan	CI

Transcript : Viracta Therapeutics, Inc. - Special Call	23-10-04
Transcript : Viracta Therapeutics, Inc. - Special Call	22-04-27
Transcript : Viracta Therapeutics, Inc. - Special Call	21-05-20

No results for this search